Using diamagnetic therapy to treat pain and inflammation
Official title: Low Frequency High Intensity- Pulsed Magnetic Fields (LF-HI-PEMF) in Pain and Inlfammation
Run by University of Catanzaro · NCT06844552 · Data updated 2026-11-12
This study is testing if a new type of magnetic therapy can help people with pain and inflammation feel better over the course of a year.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Catanzaro Academic / other |
| Locations | 2 sites (Catanzaro, Italia and 1 other locations) |
| Status | Recruiting |
| Started | February 19, 2025 |
| Main results expected | July 19, 2025 |
| Study ends | February 28, 2027 |
| Registry record updated | February 25, 2025 |
| Trial ID | NCT06844552 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 to 75 with significant pain or inflammation who have not benefited from systemic treatments.
✕Probably not a fit
Patients with active malignancies, infections, or neurological disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical study investigates the effects of Low Frequency High Intensity-Pulsed Magnetic Fields (LF-HI-PEMF) on patients suffering from pain and inflammation. Patients are enrolled and monitored over a year, with assessments at baseline and follow-up intervals of 30 days, 60 days, 90 days, and 360 days. The study aims to evaluate the efficacy of this therapy by measuring changes in pain levels using the Visual Analogue Scale (VAS). Additionally, questionnaires are administered to gather clinical and laboratory data throughout the study.
Why it matters
Potential benefit: If successful, this therapy could provide a non-invasive treatment option for patients with chronic pain and inflammation who have not responded to traditional medications.
How similar studies have gone: While the specific approach of LF-HI-PEMF is less common, similar therapies have shown promise in managing pain and inflammation in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients of both sexes between 18 and 75 years old 2. Patients with pain and or inflammation (e.g. osteoarthritis, trauma, prostatitis) 3. Patients with VAS (Visual Analogue Scale) intensities higher than 5/10 who did not respond to systemic medication therapy. 4. Patients who can comprehend the study's objectives and adhere to the clinical instructions, return for follow-up, and complete the evaluation questionnaires. 5. Patients able to provide their written informed consent to participate to the study and to use their data anonymously for scientific purposes Exclusion Criteria: 1. presence of active malignancy of any type or history of malignancy 2. Local or systemic infection. 3. Uncooperative patient or suffering from neurological disorders, therefore unable to follow the clinical instructions or unable to provide informed consent for participation in the study or who have not provided written consent. 4. Any case not described in the inclusion criteria. Patients with contraindication to magnetic resonance imaging
Where it's running
-
AOU Dulbecco Catanzaro
Catanzaro, Italia, Italy Recruiting -
Luca Gallelli
Catanzaro, Italy Recruiting
Study contacts
- Study coordinator: Luca Gallelli, MD
- Email: gallelli@unicz.it
- Phone: 0961712322
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.